학술논문
Conventional vs. Hypofractionated, Radiotherapy for High-Risk Prostate Cancer: 7-Year Outcomes of the Randomized, Non-Inferiority, Phase 3 PCS5 Trial
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:S3-S3
Subject
Language
ISSN
0360-3016